natgillin/translations-raw huggingface dataset:
Pred dajanjem zdravila je treba 5 ml koncentrata iz ene viale ali potrebno izvlečeno količino koncentrata dodatno razredčiti s 100 ml raztopine za infundiranje brez kalcija (0,9% m/v raztopine natrijevega klorida ali 5% m/v raztopine glukoze).
Prior to administration, 5 ml concentrate from one vial or the volume of the concentrate withdrawn as required must be further diluted with 100 ml of calcium-free infusion solution (0.9% w/v sodium chloride solution or 5% w/v glucose solution).
Pred dajanjem zdravila Zoledronska kislina Actavis in po njem je treba preveriti stanje bolnikove hidracije in tako zagotoviti, da je ustrezno hidriran.
The hydration status of patients must be assessed prior to and following administration of Zoledronic acid Actavis to ensure that they are adequately hydrated.
Pred injiciranjem jo morate vizualno pregledati, ali vsebuje delce in ali je obarvana.
The solution should be visually inspected for particulate matter or discoloration prior to administration.
Pred injiciranjem zdravniku povejte o vseh vaših boleznih.
Make sure you tell your doctor about any illness you have before treatment.
Pred liečbou a počas nej je potrebné sledovať klírens kreatinínu.
Creatinine clearance must be monitored prior to and during treatment.
Pred liečbou sa má zvážiť konzervácia spermií alebo vajíčok vzhľadom na možnosť nezvratnej neplodnosti spôsobenej liečbou Yondelisom.
Advice on conservation of ovules or sperm should be sought prior to treatment because of the possibility of irreversible infertility due to therapy with Yondelis.
Pred naslednjo uporabo topotekana mora biti število nevtrofilcev ≥ 1 x 109/l, število trombocitov ≥ 100 x 109/l, vrednost hemoglobina pa ≥ 9 g/dl (po transfuziji, če je le-ta potrebna).
Topotecan should not be re-administered unless the neutrophil count is ≥ 1 x 109/l, the platelet count is ≥ 100 x 109/l, and the haemoglobin level is ≥ 9 g/dl (after transfusion if necessary).
Pred odmerjanjem preverite izgled razredčene raztopine.
Visually inspect the diluted solution before administration.
Pred odmerjanjem preverite izgled razredčene raztopine.
Visually inspect the diluted solution before infusion.
Pred opakovanou liečbou musí pacient spĺňať vyššie definované základné kritériá.
Prior to re-treatment, patients must fulfil the baseline criteria defined above.
Pred použitím si prečítajte písomnú informáciu pre používateľa.
Read the package leaflet before use.
Pred prvim ciklom zdravljenja s topotekanom morajo imeti bolniki izhodiščno število nevtrofilcev ≥ 1,5 x 109/l in število trombocitov ≥ 100 x 109/l ter raven hemoglobina ≥ 9g/dl (po transfuziji, če je le-ta potrebna).
Prior to administration of the first course of topotecan, patients must have a baseline neutrophil count of ≥ 1.5 x 109/l, and a platelet count of ≥ 100 x 109/l and a haemoglobin level of ≥ 9 g/dl (after transfusion if necessary).
Pred prvim ciklom zdravljenja s topotekanom morajo imeti bolniki izhodiščno število nevtrofilcev ≥ 1,5 x 109/l, število trombocitov ≥ 100 x 109/l ter raven hemoglobina ≥ 9 g/dl (po transfuziji, če je le-ta potrebna).
Prior to administration of the first course of topotecan, patients must have a baseline neutrophil count of ≥ 1.5 x 109/l, a platelet count of ≥ 100 x 109/l and a haemoglobin level of ≥ 9 g/dl (after transfusion if necessary).
Pred subkutanim injiciranjem jo morate vizualno pregledati, ali vsebuje delce in ali je obarvana.
The solution should be visually inspected for particulate matter or discoloration prior to subcutaneous administration.
Pred uporabo dobro pretresite.
Shake well before use.
Pred uporabo je treba topotekan rekonstituirati in nato še nadalje razredčiti (glejte poglavje 6.6).
Topotecan must be further diluted before use (see section 6.6) Posology
Pred uporabo je treba topotekan rekonstituirati in nato še nadalje razredčiti (glejte poglavje 6.6).
Topotecan must be further diluted before use (see section 6.6).
Pred uporabo natančno preberite navodilo!
Read all of this leaflet carefully before you start using this medicine.
Pred uporabo natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Pred uporabo natančno preberite navodilo.
Read the package leaflet before use.
Pred uporabo PhotoBarra prenehajte dojiti.
You should stop breast-feeding before using PhotoBarr.
Pred uporabo preberite navodila za pripravo, glejte poglavje 6.6
For instructions on reconstitution prior to administration, see section 6.6
Pred uporabo preberite navodila za pripravo, glejte poglavje 6.6
For instructions on reconstitution prior to administration, see section 6.6.
Pred uporabo preberite navodilo.
Read the package leaflet before use.
Pred uporabo preberite priloženo besedilo.
Read the package leaflet before use.
Pred uporabo preberite priloženo navodilo!
Read the package leaflet before use.
pred uporabo preverite, ali je oprema v dobrem stanju
the good condition of the material should be checked before use
Pred uporabo tega zdravila se posvetujte z zdravnikom v naslednjih primerih:
Tell your doctor before you start to take this medicine if:
Pred uporabo zdravila Zoledronska kislina Actavis je treba bolnike pregledati in tako preveriti, da so ustrezno hidrirani.
Patients must be assessed prior to administration of Zoledronic acid Actavis to ensure that they are adequately hydrated.
Pred vsakim injiciranjem zdravniku povejte o vseh vaših boleznih.
Make sure you tell your doctor about any illness you have before each treatment.
pred vsako uporabo regulator tlaka očistite z mešanico dušika in dušikovega oksida, da bi preprečili vdihovanje dušikovega dioksida regulatorja tlaka ne smete privijati s kleščami, da ne zdrobite tesnila
the pressure regulator should be purged by the nitrogen-nitric oxide mixture before each new use in order to preclude nitrogen dioxide inhalation the pressure regulator should not be tightened with pliers, at the risk of crushing the gasket
Pred začatím liečby Yondelisom oznámte svojmu lekárovi, ak viete alebo sa domnievate, že máte akékoľvek problémy s pečeňou, obličkami alebo srdcom.
Tell your doctor if you know or suspect that you have any liver, kidney or cardiac problems before starting the treatment with Yondelis.
Pred začetkom jemanja natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Pred začetkom jemanja zdravila natančno preberite navodilo, ker za vsebuje za vas pomembne podatke!
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Pred začetkom jemanja zdravila Pramipeksol Accord se posvetujte s svojim zdravnikom.
Talk to your doctor before taking Pramipexole Accord.
Pred začetkom jemanja zdravila Pravafenix morate biti na dieti za zniževanje holesterola.
Before starting taking Pravafenix, you should be on a diet to lower your cholesterol.
Pred začetkom jemanja zdravila Teysuno se posvetujte z zdravnikom:
Talk to your doctor before taking Teysuno if you have:
Pred začetkom uporabe natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Pred začetkom uporabe zdravila natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Pred začetkom uporabe zdravila Pemetreksed Hospira se posvetujte s svojim zdravnikom ali z bolnišničnim farmacevtom.
Talk to your doctor or hospital pharmacist before receiving Pemetrexed Hospira.
Pred začetkom uporabe zdravila Pravafenix se posvetujte z zdravnikom ali farmacevtom.
Talk to your doctor or pharmacist before taking Pravafenix.
Pred začetkom uporabe zdravila Stelara se posvetujte z zdravnikom ali farmacevtom.
Talk to your doctor or pharmacist before using Stelara.
Pred začetkom uporabe zdravila Stelara, svojemu zdravniku povejte:
Before you use Stelara tell your doctor:
Pred začetkom uporabe zdravila Tpoptekan Teva se posvetijte z zdravnikom ali medicinsko sestro: če imate kakršnekoli težave z ledvicami.
Talk to your doctor or nurse before using Topotecan Teva: if you have any kidney problems.
Pred začetkom zdravljenja je treba prenehati dojiti.
Breast-feeding should be terminated prior to treatment.
Pred začetkom zdravljenja z zdravilom STELARA je treba zdravljenje tuberkuloze uvesti tudi pri bolnikih, ki imajo v anamnezi latentno ali aktivno tuberkulozo in pri njih ni mogoče potrditi, da so opravili ustrezen ciklus zdravljenja.
Anti-tuberculosis therapy should also be considered prior to initiation of STELARA in patients with a history of latent or active tuberculosis in whom an adequate course of treatment cannot be confirmed.
Pred začetkom zdravljenja z zdravilom Zoledronska kislina Actavis je treba izmeriti vrednost kalcija v serumu in odpraviti morebitno hipokalciemijo.
Serum calcium should be measured and hypocalcaemia must be corrected before initiating zoledronic acid therapy.
Pred začetkom zdravljenja, bo zdravnik ocenil vaše zdravstveno stanje.
Your doctor will check how well you are before each treatment.
Pred začetkom zdravljenja, bo zdravnik ocenil vaše zdravstveno stanje.
Your doctor will check how well you are before treatment.
Pred začetkom zdravljenja:
Before initiating therapy,
Pred zdravljenjem z zdravilom INOmax povejte zdravniku, če ste noseči, menite, da bi lahko bili noseči, ali če dojite.
Tell your doctor before treatment with INOmax if you are pregnant, think you could be pregnant or are breastfeeding
Preden boste prejeli zdravilo Palonosetron Hospira se posvetujte z zdravnikom ali farmacevtom:
Talk to your doctor or pharmacist before you are given Palonosetron Hospira:
Preden dobite to zdravilo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Preden greste po injekcijo PhotoBarra, se prepričajte, da so v vašem domu nameščeni ustrezni senčniki in zavese, ki vas ščitijo pred močno sončno svetlobo.
Before you go to receive your PhotoBarr injection, check that there are adequate shades and curtains in your home to keep out bright sunlight.
Preden začnete jemati zdravilo Pravafenix, mora zdravnik opraviti preiskavo vaše krvi.
Your doctor should do a blood test before you start taking Pravafenix.
Predihavanje s prekinitvami pretoka pri novorojenčku je lahko povezano z znatnimi dvigi koncentracije dušikovega oksida.
Intermittent flow neonatal ventilation may be associated with spikes in nitric oxide concentration.
Predklinické údaje o bezpečnosti
Preclinical safety data
Predklinické údaje preukázali, že trabektedín je substrátom pre P-gp.
Preclinical data have demonstrated that trabectedin is a substrate to P-gp.
Predklinične raziskave so pokazale, da topotekan povzroča smrt in deformacije zarodka oziroma ploda (glejte poglavje 5.3).
Topotecan has been shown to cause embryo-foetal lethality and malformations in preclinical studies (see section 5.3).
Predklinične študije kažejo na to, da palonosetron lahko blokira ionske kanalčke udeležene pri ventrikularni de in repolarizaciji, ter s tem podaljša trajanje akcijskega potenciala le v zelo visokih koncentracijah.
Non-clinical studies indicate that palonosetron, only at very high concentrations, may block ion channels involved in ventricular de- and re-polarisation and prolong action potential duration.
Predklinične študije kažejo, da se topotekan le malo veže na beljakovine v plazmi (35 %), precej enakomerno pa se razporedi med krvnimi celicami in plazmo.
Preclinical studies indicate plasma protein binding of topotecan is low (35 %) and distribution between blood cells and plasma was fairly homogeneous.
Predklinični podatki o varnosti
5.3 Preclinical safety data
Predklinični podatki o varnosti
Pharmacodynamic properties
Predklinični podatki o varnosti
Preclinical safety data
Predklinični podatki prav tako kažejo na ishemijo tkiva, alopurinol, blokatorji kalcijevih kanalčkov in nekateri zaviralci sinteze prostaglandina pa bi lahko vplivali na zdravljenje s PhotoBarrom PDT.
Preclinical data also suggest that tissue ischaemia, allopurinol, calcium channel blockers and some prostaglandin synthesis inhibitors could interfere with PhotoBarr PDT.
Prednost p- vrednost
Superio rity p- value
Prednostna p-vrednost (RT)
Non-inferiority p-value (HR)
Predpisovanje dušikovega oksida mora nadzirati zdravnik z izkušnjami v intenzivni negi novorojenčkov.
Prescription of nitric oxide should be supervised by a physician experienced in neonatal intensive care.
Predpisovanje dušikovega oksida mora nadzorovati zdravnik z izkušnjami s kardiotorakalno anestezijo in intenzivno nego.
Prescription of nitric oxide should be supervised by a physician experienced in cardiothoracic anaesthesia & intensive care.
Predpisovanje in izdaja zdravila je le na recept s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Predpisovanje in izdaja zdravila je le na recept.
Medicinal product subject to medical prescription
Predpisovanje in izdaja zdravila je le na recept.
Medicinal product subject to medical prescription.
Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2)
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .
Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Predpisovanje mora biti omejeno na kardiotorakalne enote, ki so ustrezno usposobljene za uporabo sistemov za dovajanje dušikovega oksida.
Prescription should be limited to those cardio-thoracic units that have received adequate training in the use of a nitric oxide delivery system.
Predpisovanje naj bo omejeno na tiste enote za novorojenčke, ki so ustrezno usposobljene za uporabo sistema za dovajanje dušikovega oksida.
Prescription should be limited to those neonatal units that have received adequate training in the use of a nitric oxide delivery system.
Predstavljajo jih predvsem reakcije, podobne sončnim opeklinam, blaga rdečina na izpostavljeni koži, navadno na obrazu in rokah.
They consist mainly of sunburn-like reactions, mild redness on exposed skin, usually the face and hands.
Predtým, ako začnete používať Yondelis, obráťte sa na svojho lekára.
Talk to your doctor before using Yondelis
Predávkovanie
Overdose
Pregabalin Mylan Pharma е лекарство, което се използва за лечение на възрастни със следните заболявания:
Pregabalin Mylan Pharma is a medicine used to treat adults with the following conditions:
Pregabalin Mylan Pharma е „генерично лекарство“.
Pregabalin Mylan Pharma is a ‘generic medicine’.
Pregabalin Mylan Pharma се предлага под формата на капсули (25, 50, 75, 100, 150, 200, 225 и 300 mg) и се отпуска по лекарско предписание.
Pregabalin Mylan Pharma is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription.
Pregabalin Mylan е лекарство, което се използва за лечение на възрастни със следните заболявания:
Pregabalin Mylan is a medicine used to treat adults with the following conditions:
Pregabalin Mylan е „генерично лекарство“.
Pregabalin Mylan is a ‘generic medicine’.
Pregabalin Mylan се предлага под формата на капсули (25, 50, 75, 100, 150, 200, 225 и 300 mg) и се отпуска по лекарско предписание.
Pregabalin Mylan is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription.
Pregabalin Mylan съдържа активното вещество прегабалин (pregabalin).
Pregabalin Mylan contains the active substance pregabalin.
Pregabalin Pfizer 100 mg
Pregabalin Pfizer 200 mg
Pregabalin Pfizer 100 mg твърди капсули
Pregabalin Pfizer 100 mg hard capsules
Pregabalin Pfizer 100 mg твърди капсули Прегабалин
Pregabalin Pfizer 200 mg hard capsules Pregabalin
Pregabalin Pfizer 150 mg твърди капсули
Pregabalin Pfizer 25 mg hard capsules Pregabalin
Pregabalin Pfizer 150 mg твърди капсули Прегабалин
Pregabalin Pfizer 225 mg hard capsules Pregabalin
Pregabalin Pfizer 200 mg твърди капсули Прегабалин
Pregabalin Pfizer 300 mg hard capsules Pregabalin
Pregabalin Pfizer 25 mg
Pregabalin Pfizer 100 mg
Pregabalin Pfizer 25 mg
Pregabalin Pfizer 75 mg
Pregabalin Pfizer 25 mg твърди капсули Pregabalin Pfizer 50 mg твърди капсули Pregabalin Pfizer 75 mg твърди капсули Pregabalin Pfizer 100 mg твърди капсули Pregabalin Pfizer 150 mg твърди капсули Pregabalin Pfizer 200 mg твърди капсули Pregabalin Pfizer 225 mg твърди капсули Pregabalin Pfizer 300 mg твърди капсули
Pregabalin Pfizer 25 mg hard capsules, Pregabalin Pfizer 50 mg hard capsules, Pregabalin Pfizer 75 mg hard capsules, Pregabalin Pfizer 100 mg hard capsules, Pregabalin Pfizer 150 mg hard capsules, Pregabalin Pfizer 200 mg hard capsules, Pregabalin Pfizer 225 mg hard capsules, Pregabalin Pfizer 300 mg hard capsules
Pregabalin Pfizer 25 mg твърди капсули Прегабалин
Pregabalin Pfizer 100 mg hard capsules Pregabalin
Pregabalin Pfizer 25 mg твърди капсули Прегабалин
Pregabalin Pfizer 75 mg hard capsules Pregabalin
Pregabalin Pfizer 300 mg твърди капсули
Pregabalin Pfizer 75 mg hard capsules Pregabalin
Pregabalin Pfizer 300 mg твърди капсули Прегабалин
Pregabalin Pfizer 300 mg hard capsules Pregabalin
Pregabalin Pfizer 50 mg твърди капсули Прегабалин
Pregabalin Pfizer 150 mg hard capsules Pregabalin
Pregabalin Pfizer 75 mg
Pregabalin Pfizer 150 mg
Pregabalin Pfizer 75 mg твърди капсули Прегабалин
Pregabalin Pfizer 150 mg hard capsules Pregabalin
Pregabalin Pfizer е предназначена само за перорално приложение.
Pregabalin Pfizer is for oral use only.
Pregabalin Pfizer може да повлияе в малка до умерена степен способността за шофиране и работа с машини.
Inter-subject pharmacokinetic variability for pregabalin is low (< 20%).
Pregabalin Pfizer може да повлияе в малка до умерена степен способността за шофиране и работа с машини.
Pregabalin Pfizer may have minor or moderate influence on the ability to drive and use machines.
Pregabalin Pfizer може да причини замъгляване или загуба на зрението, или други промени в зрeнието, много от които са временни.
Pregabalin Pfizer may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Pregabalin Pfizer не трябва да бъде вземана по време на бременност или кърмене, освен ако Вашият лекар не Ви е казал друго.
Pregabalin Pfizer should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor.
Pregabalin Pfizer принадлежи към група лекарства, които се използват за лечение на епилепсия, невропатна болка и генерализирано тревожно разстройство (ГТР) при възрастни.
Pregabalin Pfizer belongs to a group of medicines used to treat epilepsy, neuropathic pain and Generalised Anxiety Disorder (GAD) in adults.
Pregabalin Pfizer с хранa, напитки и алкохол
Pregabalin Pfizer with food, drink and alcohol
Pregabalin Pfizer съдържа лактоза монохидрат
Pregabalin Pfizer contains lactose monohydrate
Pregabalin Sandoz
Pregabalin Sandoz Pregabalin Sandoz
Pregabalin Sandoz GmbH
Pregabalin Sandoz
Pregabalin Sandoz GmbH е „генерично лекарство“.
Pregabalin Sandoz GmbH is a ‘generic medicine’.
Pregabalin Sandoz Pregabalin Sandoz
Pregabalin Sandoz
Pregabalin Sandoz Pregabalin Sandoz
Pregabalin Sandoz Pregabalin Sandoz Pregabalin Sandoz
Pregabalin Sandoz е „генерично лекарство“.
Pregabalin Sandoz is a ‘generic medicine’.
Pregabalin Zentiva 100 mg твърди капсули са опаковани в блистери от PVC/алуминий като първична опаковка.
Pregabalin Zentiva 100 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 150 mg твърди капсули са опаковани в блистери от PVC/алуминий като първична опаковка.
Pregabalin Zentiva 150 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 200 mg твърди капсули са опаковани в блистери от PVC/алуминий като първична опаковка.
Pregabalin Zentiva 200 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 225 mg твърди капсули са опаковани в блистери от PVC/алуминий като първична опаковка.
Pregabalin Zentiva 225 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 300 mg твърди капсули са опаковани в блистери от PVC/алуминий като първична опаковка.
Pregabalin Zentiva 300 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 50 mg твърди капсули са опаковани в блистери от PVC/алуминий (PVC/Аl) като първична опаковка.
Pregabalin Zentiva 50 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva съдържа лактоза монохидрат.
Pregabalin Zentiva contains lactose monohydrate.
Preglednica 1
Table 1
Preglednica 1 Začetno intravensko odmerjanje zdravila STELARA
Table 1 Initial intravenous dosing of STELARA
Preglednica 1.
Table 1.
Preglednica 1: Odstotek bolnikova, ki reagirajo na zdravljenje glede na vrsto in stopnjo zdravljenja v študiji zmerno emetogene kemoterapije v primerjavi z ondansetronom
Table 1: Percentage of patients a responding by treatment group and phase in the Moderately Emetogenic Chemotherapy study versus ondansetron
Preglednica 1: Parkinsonova bolezen
Table 1: Parkinson’s disease
Preglednica 1: Standardni odmerek in zmanjšana odmerka, dopustna za zdravilo Teysuno in/ali cisplatin
Table 1: Standard dose and dose reductions allowed for Teysuno and/or for cisplatin
Preglednica 2 - Preglednica za prilagajanje odmerkov zdravila Pemetreksed Hospira (kot edine učinkovine ali v kombinaciji) in cisplatina – Nehematološke toksičnosti a, b
Dose modification table for Pemetrexed Hospira (as single agent or in combination) and cisplatin - Non-haematologic toxicities a, b
Preglednica 2 Volumen raztopine zdravila STELARA pri pediatričnih bolnikih s psoriazo in teleso maso < 60 kg
Table 2 Injection volumes of STELARA for paediatric psoriasis patients < 60 kg
Preglednica 2.
Table 2.
Preglednica 2: Izračuni standardnih in zmanjšanih odmerkov glede na telesno površino (m2)
Table 2: Standard and reduced dose calculations by body surface area (m2)
Preglednica 2: Odstotek bolnikova, ki reagirajo na zdravljenje glede na vrsto in stopnjo zdravljenja v študiji zmerno emetogene kemoterapije v primerjavi z dolasetronom
Table 2: Percentage of patients a responding by treatment group and phase in the Moderately Emetogenic Chemotherapy study versus dolasetron
Preglednica 2: Rezultati učinkovitosti (bolniki z rakom prostate, ki prejemajo hormonsko zdravljenje)
Table 2: Efficacy results (prostate cancer patients receiving hormonal therapy)
Preglednica 2: Seznam neželenih učinkov
System Organ Class
Preglednica 2: Seznam neželenih učinkov
Table 2 List of adverse reactions
Preglednica 3: Indukcija kliničnega odziva in klinične remisije v študijah UNITI-1 in UNITI-2
Table 3: Induction of Clinical Response and Remission in UNITI-1 and UNITI 2
Preglednica 3: Načrt za zmanjšanje odmerka zdravila Teysuno zaradi toksičnosti, povezane z zdravljenjem, na splošno, razen hematološke in ledvične toksičnosti
Table 3: Teysuno dose reduction schedule for treatment-related toxicities in general, except for haematologic and renal toxicities
Preglednica 3: Odstotek bolnikova, ki reagirajo na zdravljenje, glede na vrsto zdravljenja in stopnjo zdravljenja v študiji visoko emetogene kemoterapije v primerjavi z ondansetronom
Table 3: Percentage of patients a responding by treatment group and phase in the Highly Emetogenic Chemotherapy study versus ondansetron
Preglednica 4.
Table 4.